Intended for healthcare professionals

Practice NIHR Alerts

Risk of breast cancer with HRT depends on therapy type and duration

BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o485 (Published 08 March 2022) Cite this as: BMJ 2022;376:o485

Linked Research

Use of hormone replacement therapy and risk of breast cancer

Read more about our NIHR Alerts series

Article tools

PDF 5 responses

Respond to this article
Print
Alerts & updates
Article alerts
Please note: your email address is provided to the journal, which may use this information for marketing purposes.

Log in or register:

Username *

Password *

Register for alerts

If you have registered for alerts, you should use your registered email address as your username
Citation tools
Download this article to citation manager

Helen Saul editor in chief, Deniz Gursul research dissemination officer, Samantha Cassidy science writer, Yana Vinogradova senior research fellow

Saul H, Gursul D, Cassidy S, Vinogradova Y. Risk of breast cancer with HRT depends on therapy type and duration BMJ 2022; 376 :o485 doi:10.1136/bmj.o485

BibTeX (win & mac)Download

EndNote (tagged)Download

EndNote 8 (xml)Download

RefWorks Tagged (win & mac)Download

RIS (win only)Download

MedlarsDownload

Help

If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

EndNote

ProCite

Reference Manager

RefWorks

Zotero
Request permissions

Minehead Medical Centre: GP Consultant - Minehead Medical Centre

Meadows Surgery: GP Opportunity (up to 8 sessions) - The Meadows Surgery, Ilminster

Quantock Vale Surgery: GP Partner (Up to 4 Sessions) - Quantock Vale Surgery

Frome Medical Practice: Senior Associate GP - Frome Medical Practice

Millbrook Surgery: Salaried GP - Millbrook Surgery